Multistate employers with employees in Texas are subject to state laws regarding employment agreements. Whether your business ...

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis ("UC”) reaches 1,003 of 1,224 ...

ASHBURN, Va., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

It’s January 3, how are you doing with your New Year's resolutions? As the new year unfolds, many people set ambitious resolutions to improve their health and lifestyle. However, a common yet ...

Shares of Verastem Oncology VSTM rallied 40.9% on Tuesday after it announced that the FDA has accepted the new drug application (NDA) for its avutometinib/defactinib ...

NDA 1 Syllabus 2025: The Union Public Service Commission (UPSC) conducts the National Defence Academy (NDA) twice every year. The NDA 1 notification 2025 has been released along with the detailed ...

Prestigious examinations like the UPSC NDA, CDS, and Agniveer serve as entry points for aspiring candidates ... Rituals should have been a main/core subject during their Shastri/Acharya studies, or ...

has announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for relacorilant, a treatment for patients with Cushing's syndrome, also known as ...